{"entity":{"id":"recordati","kind":"company","name":"Recordati","aka":[],"tldr":"Recordati is an Italian pharmaceutical group whose rare-disease arm markets oncology and haematology products in Europe, including siltuximab (Sylvant), chlormethine gel (Ledaga) and dinutuximab beta (Qarziba).","summary":"Recordati, based in Milan and listed as REC.MI, is an Italian pharmaceutical group whose rare disease arm markets oncology and haematology products in Europe, including siltuximab, sold as Sylvant, chlormethine gel, sold as Ledaga, and dinutuximab beta, sold as Qarziba. Recordati Rare Diseases acquired EUSA Pharma in 2022, adding Sylvant for multicentric Castleman disease, Qarziba for high-risk neuroblastoma and Fotivda, or tivozanib, in Europe, alongside Ledaga licensed from Helsinn. OnCo links it to siltuximab and mechlorethamine. Whether a rare disease marketer can keep paediatric and ultra-rare oncology products available across Europe at prices health systems accept is the open question. Siltuximab has its own page.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.recordati.com"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["dactinomycin"],"companies":["helsinn"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Milan","country":"IT","companyType":"pharma","website":"https://www.recordati.com","ticker":"REC.MI","investors":[],"funding":[]},"route":"/companies/recordati/","neighbours":{"drug":[{"id":"dactinomycin","kind":"drug","name":"Dactinomycin (actinomycin D)","route":"/drugs/dactinomycin/"},{"id":"mechlorethamine","kind":"drug","name":"Mechlorethamine (chlormethine)","route":"/drugs/mechlorethamine/"},{"id":"osilodrostat","kind":"drug","name":"Osilodrostat","route":"/drugs/osilodrostat/"},{"id":"pasireotide","kind":"drug","name":"Pasireotide","route":"/drugs/pasireotide/"},{"id":"siltuximab","kind":"drug","name":"Siltuximab","route":"/drugs/siltuximab/"}],"company":[{"id":"helsinn","kind":"company","name":"Helsinn","route":"/companies/helsinn/"}]}}